KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Liabilities and Shareholders Equity: 2017-2025

Historic Liabilities and Shareholders Equity for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $13.6 billion.

  • Elanco Animal Health's Liabilities and Shareholders Equity rose 2.02% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 billion, marking a year-over-year decrease of 4.65%. This contributed to the annual value of $12.6 billion for FY2024, which is 12.17% down from last year.
  • As of Q3 2025, Elanco Animal Health's Liabilities and Shareholders Equity stood at $13.6 billion, which was down 1.39% from $13.7 billion recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Liabilities and Shareholders Equity registered a high of $17.0 billion during Q1 2021, and its lowest value of $12.6 billion during Q4 2024.
  • Over the past 3 years, Elanco Animal Health's median Liabilities and Shareholders Equity value was $13.8 billion (recorded in 2024), while the average stood at $14.0 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 74.64% in 2021, then declined by 12.86% in 2024.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Liabilities and Shareholders Equity stood at $16.5 billion in 2021, then decreased by 5.99% to $15.5 billion in 2022, then fell by 7.29% to $14.4 billion in 2023, then dropped by 12.17% to $12.6 billion in 2024, then grew by 2.02% to $13.6 billion in 2025.
  • Its Liabilities and Shareholders Equity was $13.6 billion in Q3 2025, compared to $13.7 billion in Q2 2025 and $12.9 billion in Q1 2025.